MS Living Well Podcast. Inside MS: Navigating Inflammation

Dive into a deeper understanding of the role of inflammation in causing injury to the brain and spinal cord in multiple sclerosis. It’s a journey marked by ups and downs, where the adaptive immune system composed of lymphocytes (T and B cells) attack myelin and the innate immune system clears damaged myelin. An immune cell called microglia can create smoldering inflammation in MS that poses a threat of progressive disability.

Explore the arsenal of MS treatment strategies developed over the past 3 decades to either alter or suppress the immune system to reduce inflammation. Triumphs and limitations of our current MS therapies shared. Antioxidant research, diet and new therapeutics tackling smoldering inflammation bring newfound hope.

Episode is sponsored by EMD Serono.

Prof. Klaus Schmierer

Klaus Schmierer MB BS, PhD, FRCP is a Professor of Neurology at the Blizard Institute, Queen Mary University of London, and Consultant Neurologist at The Royal London Hospital, Barts Health NHS Trust, where he is the Research Lead for Neurology. He completed his neurology training at the Charité Hospital at Humboldt University in Berlin. His MS research interests include epidemiology and cause(s) of MS, quantitative MRI imaging and clinical trials.

Michael Kornberg MD PhD

Michael Kornberg MD, PhD is an Assistant Professor of Neurology at John Hopkins. He completed college at Yale University. He received M.D. and Ph.D. degrees from the Johns Hopkins School of Medicine and stayed at Johns Hopkins for neurology residency and a clinical and research fellowship in neuroimmunology. Dr. Kornberg conducts research aimed at better understanding the processes that drive MS progressive disability such a neurodegeneration and remyelination failure.